13F HOLDINGS REPORT
Vida Ventures Advisors, LLC
Quarter ended Q2 2023 · Filed April 13, 2023 · Accession 0000950123-23-003235
Total Value
$73.1M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Dyne Therapeutics, Inc. | DYN | 2,220,034 | $25.6M | 34.99% |
| 2 | Centessa Pharmaceuticals plc | CNTA | 3,931,818 | $15.1M | 20.71% |
| 3 | Kinnate Biopharma, Inc. | 49705R105 | 2,207,772 | $13.8M | 18.88% |
| 4 | Allogene Therapeutics, Inc. | ALLO | 1,798,163 | $8.9M | 12.15% |
| 5 | LianBio | LIANY | 2,282,084 | $4.5M | 6.12% |
| 6 | Kronos Bio, Inc. | 50107A104 | 2,765,314 | $4.0M | 5.52% |
| 7 | Praxis Precision Medicines, Inc. | PRAX | 1,469,665 | $1.2M | 1.63% |